By Tom Philpott Dodgy companies peddling pricey compound pharmaceuticals have fleeced the TRICARE program so severely this year, before tougher screening procedures took effect May 1, that they are largely to blame for a $2 billion defense health budget hole Congress is scrambling to fill. In fiscal 2010, military outpatient pharmacy costs totaled $6.6 billion, […]
↧